A phase I study of DKN-01 (D), an anti-DKK1 monoclonal antibody, in co

Discussion Board › Forums › Clinical Trials › A phase I study of DKN-01 (D), an anti-DKK1 monoclonal antibody, in co

Viewing 1 post (of 1 total)
  • Author
    Posts
  • May 18, 2017 at 5:48 pm #13362
    gavin
    Moderator

    A phase I study of DKN-01 (D), an anti-DKK1 monoclonal antibody, in combination with gemcitabine (G) and cisplatin (C) in patients (pts) for first-line therapy with advanced biliary tract cancer (BTC).

    http://abstracts.asco.org/199/AbstView_199_182654.html

    Please note that information regarding clinical trials is being provided for informational purposes only. The Cholangiocarcinoma Foundation does not endorse any specific clinical trial. Please discuss any questions you may have about clinical trials with your healthcare provider.

  • Author
    Posts
Viewing 1 post (of 1 total)
  • The forum ‘Clinical Trials’ is closed to new topics and replies.